Fund
New Leaf Venture Partners
New Leaf Venture Partners took part in the round of Star Therapeutics (200 M$) on 23 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
Get New Leaf Venture Partners's next deals
An email each time this fund appears in a new health deal, plus the Friday newsletter. Nothing else.
Free. One click to unsubscribe. The list is never sold. In French.
- Operations logged
- 1
- Lead
- 0
- New entries
- 1
- Follow ons
- 0
- Latest operation
- 23 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 23 Oct | United States, Biotech | 200 M$ | Participant |
Co investors 10 funds crossed
- Agent Capital 1 operation
- Catalio Capital Management 1 operation
- Cormorant Asset Management 1 operation
- Janus Henderson Investors 1 operation
- NYBC Ventures 1 operation
- OrbiMed 1 operation
- RA Capital Management 1 operation
- Redmile 1 operation
- Sofinnova Investments 1 operation
- Soleus Capital 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.